References - Therapeutic Strategies in Cancer Biology and Pathology - page 264

Zhang, Y., Wang, Y., Bao, C., Xu, Y., Shen, H., Chen, J., et al., 2012e. Metformin interacts
with AMPK through binding to gamma subunit. Mol. Cell. Biochem. 368, 69-76.
Zhang, Z., Liu, Z.B., Ren, W.M., Ye, X.G., Zhang, Y.Y., 2012f. The miR-200 family regulates
the epithelial-mesenchymal transition induced by EGF/EGFR in anaplastic thyroid can-
cer cells. Int. J. Mol. Med. 30, 856-862.
Zhao, B., Wei, X., Li, W., Udan, R.S., Yaang, Q., Xie, J., et al., 2007a. Inactivation of YAP
oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth
control. Genes Dev. 21, 2747-2761.
Zhao, C., Matthews, J., Tujague, M., Wan, J., Ström, A., Toresson, G., et al., 2007b. Estrogen
receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in
human breast cancer cells. Cancer Res. 67, 3955-3962.
Zhao, H.B., Wang, C., Li, R.X., Tang, C.L., Li, M.Q., Du, M.R., et al., 2010. E-Cadherin, as a
negative regulator of invasive behavior of human trophoblast cells, is down-regulated by
cyclosporin A via epidermal growth factor/extracellular signal-regulated protein kinase
signaling pathway. Biol. Reprod. 83, 370-376.
Zhao, J., Du, Y., Horton, J.R., Upadhyay, A.K., Lou, B., Bai, Y., et al. 2011. Discovery and
structural charactersization of a small molecule 14-3-3 protein-protein interaction inhibi-
tor. Proc. Natl. Acad. Sci. USA 108, 16212-16216.
Zheng, G.P., Xiong, Y., Yi, S., Zhang, W., Peng, B., Zhang, Q., et al., 2012. 14-3-3 sigma regu-
lation by p53 mediates a chemotherapy response to 5-fluorouracil in MCF-7 breast can-
cer cells via Akt inactivation. FEBS Lett. 586, 163-168.
Zheng, H., Ying, H., Yan, H., Kimmelman, A.C., Hiller, D.J., Chen, A.J., et al., 2008. p53 and
Pten control neural and glioma stem/progenitor cell renewal and differentiation. Nature
455 1129-U13
Zheng, J., Xue, H., Wang, T., Jiang, Y., Liu, B., Li, J., et al., 2011. miR-21 downregulates the
tumor suppressor P12CDK2AP1 and stimulates cell proliferation and invasion. J. Cell.
Biochem. 112, 872-880.
Zheng, X., Yao, Y., Xu, Q., Tu, K., Liu, Q., 2010. Evaluation of glioma-associated oncogene
1 expression and its correlation with the expression of sonic hedgehog, E-cadherin and
S100a4 in human hepatocellular carcinoma. Mol. Med. Rep. 3, 965-970.
Zhong, D., Liu, X., Khuri, F.R., Sun, S.Y., Vertino, P.M., Zhou, W., 2008. LKB1 is
necessary for Akt-mediated phosphorylation of proapoptotic proteins. Cancer Res. 68,
7270-7277.
Zhou, A.D., Diao, L.T., Xu, H., Xiao, Z.D., Li, J.H., Zhou, H., et al., 2012a. Beta-Catenin/
LEF1 transactivates the microRNA-371-373 cluster that modulates the Wnt/beta-catenin-
signaling pathway. Oncogene 31, 2968-2978.
Zhou, J., Huang, W., Tao, R., Ibaragi, S., Lan, F., Ido, Y., et al., 2009. Inactivation of AMPK
alters gene expression and promotes growth of prostate cancer cells. Oncogene 28,
1993-2002.
Zhou, L., Ercolano, E., Ammoun, S., Schmid, M.C., Barczyk, M.A., Hanemann, C.O., 2011a.
Merlin-Deficient human tumors show loss of contact inhibition and activation of Wnt/
beta-catenin signaling linked to the PDGFR/Src and Rac/PAK pathways. Neoplasia 13,
1101-1112.
Zhou, M., Liu, Z., Zhao, Y., Ding, Y., Liu, H., Xi, Y., et al., 2010a. MicroRNA-125b confers
the resistance of breast cancer cells to Paclitaxel through suppression of pro-apoptotic
Bcl-2 antagonist killer 1 (Bak1) expression. J. Biol. Chem. 285, 21496-21507.
Zhou, Q., Lui, V.W.Y., Lau, C.P.Y., Cheng, S.H., Ng, M.H.L., Cai, Y., et al., 2012b. Sustained
antitumor activity by co-targeting mTOR and the microtubule with temsirolimus/vinblas-
tine combination in hepatocellular carcinoma. Biochem. Pharmacol. 83, 1146-1158.